Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: Principal results of the mersy study

Irina Chazova, Markus P. Schlaich

Research output: Contribution to journalArticle

24 Citations (Scopus)

Fingerprint Dive into the research topics of 'Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: Principal results of the mersy study'. Together they form a unique fingerprint.

Medicine & Life Sciences